Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock, returning 12,497.4%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 12,497.44% |
Kindly MD, Inc Warrants (KDLYW) | 9,775% |
Kindly (NAKAW) | 4,156.25% |
DeFi Development (DFDV) | 3,335.87% |
K Wave Media (KWMWW) | 2,230.1% |
HCM II Acquisition (HONDW) | 1,994.83% |
Maiden (MHLD) | 1,900% |
Diginex Limited Ordinary Shares (DGNX) | 1,409.39% |
M3-Brigade Acquisition V Corp Warrant (MBAVW) | 1,011.11% |
Bolt Biotherapeutics (BOLT) | 992.92% |
Asset Entities Inc Class B Common Stock (ASST) | 992% |
Kindly (NAKA) | 976.61% |
Kindly MD, Inc Common Stock (KDLY) | 976.61% |
Nektar Therapeutics (NKTR) | 818.5% |
TMC the metals company Inc Warrants (TMCWW) | 770.57% |
Oncology Institute (TOI) | 749.67% |
Oncology Institute (TOIIW) | 733.33% |
Global Interactive Technologies (GITS) | 684.23% |
Protagenic Therapeutics (PTIXW) | 669.23% |
Abits (ABTS) | 602.19% |
Dave Inc Warrants (DAVEW) | 555.84% |
Webull Corporation Warrants (BULLW) | 548.58% |
USA Rare Earth (USARW) | 541% |
Top KingWin (WAI) | 478.95% |
Dominari (DOMH) | 459.63% |
